[1]
Marcellusi, A., Bini, C., Rotundo, M.A., Arcangeli, E., Martinez, L., Sorio Vilela, F. and Mennini, F.S. 2021. Cost-utility analysis of evolocumab in patients with ASCVD in Italy. Global and Regional Health Technology Assessment. 8, 1 (Nov. 2021), 155–167. DOI:https://doi.org/10.33393/grhta.2021.2255.